Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk

Journal of the National Cancer Institute

Volumn 106, Issue 3, 2014, Pages

  Kristal, Alan R ^a,b   Darke, Amy K ^a   Morris, J Steven ^c,d   Tangen, Catherine M ^a   Goodman, Phyllis J ^a   Thompson, Ian M ^e   Meyskens Jr , Frank L ^f   Goodman, Gary E ^b   Minasian, Lori M ^g   Parnes, Howard L ^g   Lippman, Scott M ^h   Klein, Eric A ⁱ  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Mays Cancer Center at UT Health San Antonio   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

ⁱ LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; SELENIUM; ANTIOXIDANT; TRACE ELEMENT; VITAMIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER PREVENTION; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; AFRICAN AMERICAN; CANADA; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DIET SUPPLEMENTATION; MIDDLE AGED; NAIL; PATHOLOGY; PROSTATE TUMOR; PUERTO RICO; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK; STATISTICS; UNITED STATES;

AFRICAN AMERICANS; AGED; ANTIOXIDANTS; CANADA; COHORT STUDIES; DIETARY SUPPLEMENTS; HUMANS; MALE; MIDDLE AGED; NAILS; NEOPLASM GRADING; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; PUERTO RICO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; SELENIUM; TRACE ELEMENTS; UNITED STATES; VITAMIN E; VITAMINS;

EID: 84898730422     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt456     Document Type: Article

References (33)

1. Lippman SM, Goodman PJ, Klein EA, et al. Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst. 2005;97(2):94-102.
2. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers. The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301(1):39-51.
3. Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011;306(14):1549-1556.
4. Hoque A, Albanes D, Lippman SM, et al. Molecular epidemiologic studies within the selenium and vitamin E cancer prevention trial (SELECT). Cancer Causes Control. 2001;12(7):627-633.
5. Duffield-Lillico AJ, Dalkin BL, Reid ME, et al. Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int. 2003;91(7):608-612.
6. Gleason DF. Histologic grading of prostate cancer: a perspective. Human Pathol. 1992;23(3):273-279.
7. Morris JS, Stampfer MJ, Willett W. Dietary selenium in humans: toenails as an indicator. Biol Trace Element Res. 1983;5(6):529-537.
8. Hunter DJ, Morris JS, Chute CG, et al. Predictors of selenium concentration in human toenails. Am J Epidemiol. 1990;132(1):114-122.
9. Longnecker MP, Taylor PR, Levander OA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr. 1991;53(5):1288-1294.
10. Longnecker MP, Stram DO, Taylor PR, et al. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology. 1996;7(4):384-390.
11. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90(16):1219-1224.
12. Morris JS, Ngwenyama RA, Guthrie JM, et al. Quality control in the neutron activation analysis of biological markers for selenium in epidemiological investigations. J Radioanal Nucl Chem. 2008;276(1):7-13.
13. Helzlsouer KJ, Huang H-Y, Alberg AJ, et al. Association between a-tocopherol, ?-tocopherol, selenium and subsequent prostate cancer. J Natl Cancer Inst. 2000;92(24):2018-2023.
14. Hurst R, Hooper L, Norat T, et al. Selenium and prostate cancer: systematic review and meta-analysis. Am J Clin Nutr. 2012;96(1):111-122.
15. World Cancer Research Fund/AICR. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, DC: AICR; 2007.
16. Etminan M, FitzGerald JM, Gleave M, et al. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 2005;16(9):1125-1131.
17. Brinkman M, Reulen RC, Kellen E, et al. Are men with low selenium levels at increased risk of prostate cancer? Eur J Cancer. 2006;42(15):2463-2471.
18. Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2011; Issue 5 No: CD005195. doi:10.1002/14651858. CD005195.pub2.
19. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 1998;90(16):1219-1224.
20. Geybels MS, Verhage BAJ, van Schooten FJ, et al. advanced prostate cancer risk in relation to toenail selenium levels. J Natl Cancer Inst. 2013;105(18):1394-1401.
21. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA. 1996;276(24):1957-1963.
22. Richman EL, Chan JM. Selenium and prostate cancer: the puzzle isn't finished yet. Am J Clin Nutr. 2012;96(1):1-2.
23. Chiang EC, Shen S, Kengeri SS, et al. Defining the optimal selenium dose for prostate cancer risk reduction: insights from the U-shaped relationship between selenium status, dna damage, and apoptosis. Dose Response. 2010;8(3):285-300.
24. Combs GF, Scott ML. Nutritional interrelationships of vitamin E and selenium. Bioscience. 1977;27(7):467-473.
25. Horvath PM, Ip C. Synergistic effect of vitamin E and selenium in the chemoprevention of mammary carcinogenesis in rats. Cancer Res. 1983;43(11):5335-5341.
26. McCormick DL, Rao KVN, Steele VE, et al. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Cancer Res. 1999;52(3):521-524.
27. Peters U, Littman AJ, Kristal AR, et al. Vitamin E and selenium supplementation and risk of prostate cancer in the VITamins And Lifestyle (VITAL) study cohort. Cancer Causes Control. 2008;19(1):75-87.
28. Kirsh VA, Hayes RB, Mayne ST et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 2006;98(4):245-254.
29. Rodriguez C, Jacobs EJ, Mondul AM, et al. Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev. 2004;13(3):378-382.
30. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men. The Physicians' Health Study II Randomized Controlled Trial. JAMA. 2009;301(1):52-62.
31. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New Engl J Med. 1994;330(15):1029-1035.
32. Garland M, Morris JS, Colditz GA, et al. Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol. 1996;144(7):653-660.
33. Mayne ST, Ferrucci LM, Cartmel B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annu Rev Nutr. 2012;32(1):369-390.